enGene Therapeutics Inc. (ENGN) Earnings Call Transcripts
About enGene Therapeutics Inc.
enGene Therapeutics Inc. (ENGN) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 5 calls on record spanning September 10, 2025 to August 11, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 5 enGene Therapeutics Inc. earnings call transcripts on record, spanning September 10, 2025 to August 11, 2026. Based on this history, enGene Therapeutics Inc. reports quarterly. The most recent call on file is dated August 11, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- ENGN
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Health Care
- Industry
- Biotechnology
- Calls on record
- 5
- First call
- September 10, 2025
- Most recent
- August 11, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Special Calls | Aug 11, 2026 | Read transcript → |
| Special Calls | May 7, 2026 | Read transcript → |
| Company Conference Presentations | Mar 10, 2026 | Read transcript → |
| Special Calls | Nov 11, 2025 | Read transcript → |
| Company Conference Presentations | Sep 10, 2025 | Read transcript → |